Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Projected Market Size and Growth Rates for the Breast Cancer Diagnostics Market From 2025 To 2029?

The market size for breast cancer diagnostics has seen a robust expansion in past years. The projected growth is from $4.68 billion in 2024 to $5.04 billion in 2025, with a compound annual growth rate (CAGR) of 7.9%. The growth seen in the historical period can be tied back to factors such as heightened awareness and screening promotions, uses of mammography for screening, advancements in technology, genetic tests, and a multidisciplinary methodology.

What Is the Projected Market Size of the Breast Cancer Diagnostics Market?

Significant expansion is anticipated in the breast cancer diagnostics market in the succeeding years. The projections suggest that the market will reach a value of $6.91 billion by 2029, growing at a compound annual growth rate (CAGR) of 8.2%. The predicted growth can be credited to various factors like personalized medicine, liquid biopsies, 3D mammography (tomosynthesis), artificial intelligence, and machine learning, as well as the advent of telemedicine and remote consultations. The forecast period also promises significant trends such as improvements in imaging technologies, increased focus on personalized medicine, the use of liquid biopsies, and the rise of AI and machine learning.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3284&type=smp

Who are the Major Competitors in the Breast Cancer Diagnostics Market Outlook?

Major companies operating in the breast cancer diagnostics market include Abbott Laboratories, Myriad Genetics Inc., Hologic Inc., Koninklijke Philips N.V., Fujifilm Holdings Corporation, GE Healthcare, Thermo Fisher Scientific Inc., Siemens AG, NanoString Technologies Inc., Gamma Medica Inc., Aurora Imaging Technology Inc., Dilon Technologies Inc., Exact Sciences Corporation, F. Hoffmann-La Roche Ltd, Micrima Limited, Provista Diagnostics Inc., Leica Biosystems Nussloch GmbH, bioTheranostics Inc., Bio-Rad Laboratories Inc., Illumina Inc., Biocept Inc., Epigenomics AG, AstraZeneca plc, Quest Diagnostics Incorporated, Agilent Technologies Inc., Cepheid, Guardant Health Inc., Invitae Corporation, Natera Inc., NeoGenomics Laboratories Inc., Oncocyte Corporation, PerkinElmer Inc., Sysmex Corporation, Veracyte Inc.

What Is Fueling Growth in the Breast Cancer Diagnostics Market?

The rise in breast cancer cases necessitates additional diagnostic equipment, thereby boosting the breast cancer diagnostics market’s demand. With breast cancer being the leading type of cancer, it affects around 2.1 million women annually and is the primary cause of cancer-related deaths among women. The primary aim of early diagnosis is to increase the detection rate of breast cancer in its early stages, allowing for more effective treatment and a decreased mortality risk. In January 2022, the American Cancer Society, a health organization from the US focused on cancer eradication, estimated that around 287,850 new cases of invasive breast cancer and 51,400 instances of DCIS would be diagnosed in American women that year, expecting about 43,250 deaths due to breast cancer. As such, the surge in breast cancer cases is predicted to propel the growth of the breast cancer diagnostics market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=3284&type=smp

Which Breast Cancer Diagnostics Market Segments Are Growing the Fastest?

The breast cancer diagnostics market covered in this report is segmented –

1) By Type: Imaging, Biopsy, Genomic Tests, Blood Tests, Other Types

2) By Technology: Fluorescent In Situ Hybridization (FISH), Comparative Genomic Hybridization (CGH), Immunohistochemical (IHC), Other Technologies

3) By Cancer Type: BRCA Breast Cancer, ER And PR Breast Cancer, HER 2 Breast Cancer, EGFR Mutation Test Breast Cancer, Other Cancer Types

4) By Diagnostic Type: Ionizing Breast Imaging Technologies, Non-ionizing Imaging Technologies

5) By End Users: Hospitals And Clinics, Cancer Research Centers, Diagnostic Laboratories, Ambulatory Surgical Centers

Subsegments:

1) By Imaging: Mammography, Ultrasound Imaging, Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET), Tomosynthesis

2) By Biopsy: Needle Biopsy, Core Needle Biopsy, Fine Needle Aspiration Biopsy (FNA), Stereotactic Biopsy

3) By Genomic Tests: Oncotype DX, MammaPrint, PAM50, BRCA1 Or 2 Testing

4) By Blood Tests: Liquid Biopsy, Circulating Tumor DNA (ctDNA) Tests, Circulating Tumor Cells (CTCs) Tests

5) By Other Types: Hormone Receptor Tests, HER2 Tests, Genetic Mutation Testing

Which Industry Trends Are Shaping the Future of the Breast Cancer Diagnostics Market?

The progression in technology is a crucial trend within the breast cancer diagnostics market. Numerous innovative methods for diagnosing and treating breast cancer have been created. Breast tomosynthesis, also known as 3D mammography, captures images of the breast from different angles and converts them into a 3D representation. In September 2022, Niramai, a Health-Tech firm from India, unveiled a unique solution named Thermalytix. It is an automatic tool for breast cancer screening and diagnosis that merges thermal imaging with AI.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/breast-cancer-diagnostics-global-market-report

Which Countries Are Leading the Breast Cancer Diagnostics Market?

North America was the largest region in the breast cancer diagnostics market in 2023. Asia-Pacific was the second largest region in the breast cancer diagnostics industry. The regions covered in the breast cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3284

This Report Delivers Insight On:

1. How big is the breast cancer diagnostics market, and how is it changing globally?

2. Who are the major companies in the breast cancer diagnostics market, and how are they performing?

3. What are the key opportunities and risks in the breast cancer diagnostics market right now?

4. Which products or customer segments are growing the most in the breast cancer diagnostics market?

5. What factors are helping or slowing down the growth of the breast cancer diagnostics market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model